Pfizer's COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA
NBC News reports on May 17, the Food and Drug Administration (FDA) announced it had authorized Pfizer-BioNTech's coronavirus booster dose for 5 to 11 year olds. The FDA says eligible recipients of a booster dose could receive the extra shot starting five months after their initial two-dose series.
UP NEXT
NOW PLAYING: Technology
Pfizer's COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA
COVER News India
UP NEXT
-
Monkeypox Vaccines Will Soon Be Available in States With High Rates
COVER News India
-
Amazon and Rite Aid Limit Emergency Contraception Purchases
-
Headstands and vegetarianism: How Paul McCartney stays fit in old age
-
COVID Patients Have a Higher Risk of Neurodegenerative Disorders, Study Finds
-
Flu vaccination 'can reduce risk of Alzheimer's disease'
-
Maternal Mortality Rate Expected to Rise in Wake of SCOTUS Ruling
-
Pfizer Says Updated COVID-19 Shot Effective Against Omicron
-
Long COVID Can Affect Children and Infants, Study Shows
-
Polio Virus Is Detected in London Sewage Sample
-
'Travel therapy' touted as a way to improve mental health
-
New Omicron Subvariants Overcome Vaccination, Prior Infections, New Study Shows
-
EU Commission Proposes Plan to Reduce the Use of Harmful Pesticides
-
Some Popular Supplements Could Be Harmful, New Federal Guidelines State
-
Court Rejects EPA Finding That Widely Used Weed Killer Does Not Cause Cancer
-
Omicron variant 'less likely to cause long Covid'
-
FDA Panel Endorses COVID Vaccines for Children Under 5
